People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

43.68USD
15 Sep 2014
Price Change (% chg)

$-0.67 (-1.51%)
Prev Close
$44.35
Open
$44.40
Day's High
$44.50
Day's Low
$43.50
Volume
758,366
Avg. Vol
755,752
52-wk High
$54.25
52-wk Low
$29.36

Search Stocks

Henwood, Geraldine 

Brief Biography

Ms. Geraldine A. Henwood is an Independent Director of Alkermes Plc. From April 2003 to September 16, 2011, Ms. Henwood served on Alkermes' board of directors. She is the Chief Executive Officer/President and director of both Recro Pharma, a privately held specialty pharmaceutical company, and interim chief executive officer and board member of Garnet BioTherapeutics, Inc., a privately held clinical stage cell therapy company, and is a consultant with Malvern Consulting Group and SCP Partners. She is the co-founder of Auxilium Pharmaceuticals, Inc. and served as its President, Chief Executive Officer and director from 1999 to 2006. Prior to founding Auxilium, Ms. Henwood founded, in 1985, a contract research organization (CRO), IBAH, Inc. Prior to founding IBAH, Ms. Henwood was employed by SmithKline Beecham in various capacities including senior medical and regulatory positions. Ms. Henwood is a member of the board of directors of MAP Pharmaceuticals, Inc., a publicly traded pharmaceutical company and LZ Therapeutics, a privately held biopharmaceutical company, and previously served as a director of ImmunoScience, Inc., a privately held vaccine development company. She is a trustee of LaSalle Academy and Neumann University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

6,587,780

Shane Cooke

3,164,580

James Frates

1,831,190

Gordon Pugh

1,965,720

Kathryn Biberstein

2,113,310

Rebecca Peterson

--
As Of 30 Mar 2013
Search Stocks